An interventional study of PEEK attachment retained obturator and metalic attachment retained obturator in Maxillary Neoplasms, sponsored by Cairo University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2021-03-03.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Patients' satisfaction evaluation and radiographic evaluation of the terminal abutments of attachment- retained maxillary obturators with metal framework versus milled PEEK framework in the management of maxillectomy cases.
Eighteen participants were randomly divided into three parallel groups (n=6). Participants of PEEK group received attachment-retained obturators with milled PEEK framework, metal group received an attachment-retained obturator with metallic framework and conventional group received conventional clasp-retained obturators with metallic framework (Control group). Evaluation included radiographic evaluation and patients' satisfaction where two scales were followed in this study, including "The Obturator Functioning Scale" and "The European Organization for Research and Treatment of Cancer Head and Neck 35" using one way ANOVA test.
Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
conventional group received conventional clasp-retained obturators with metallic framework (Control group).
Other: conventional obturator
metal group received an attachment-retained obturator with metallic framework
Other: metalic attachment retained obturator
PEEK group received attachment-retained obturators with milled PEEK framework,
Other: PEEK attachment retained obturator
attachment retained obturator for management of hemi maxillectomy
Also known as: milled PEEK obturator
attachment retained obturator for management of hemi maxillectomy
Also known as: attachment retained obturator
clasp retained obturator for management of hemi maxillectomy
Also known as: clasp retained obturator
patient satisfaction 1(change" is being assessed)
The Obturator Functioning Scale ( minimum value is "1"and maximum value is "5"
Time frame: 1 week to 6 months
patient satisfaction 2 (change" is being assessed)
The European Organization for Research and Treatment of Cancer Head and Neck 35 ( minimum value is "1"and maximum value is "5"
Time frame: 1 week to 6 months
Radiographic evaluation (change" is being assessed)
evaluation of terminal abutment
Time frame: base line,6 months, 9 months,12 months
Plan to share: Undecided — finished work will be published
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Maxillary Neoplasms
Cairo University